Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

Carcinogenesis

Volumn 31, Issue 12, 2010, Pages 2165-2171

  Villa Morales, María ^a,b   González Gugel, Elena ^a   Shahbazi, Marta N ^c   Santos, Javier ^a,b   Fernández Piqueras, José ^a,b  

^a CSIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA RECOMBINATION; GAMMA RADIATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; LYMPHOBLASTOMA; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; T CELL LYMPHOBLASTIC LYMPHOMA; WILD TYPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; POLYMORPHISM, GENETIC; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION;

EID: 78649766263     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq201     Document Type: Article

References (37)

1. Baumann,S. et al. (2002) Regulation of T cell apoptosis during the immune response. Curr. Mol. Med., 2, 257-272.
2. Castro,J.E. et al. (1996) Fas modulation of apoptosis during negative selection of thymocytes. Immunity, 5, 617-627.
3. Fleck,M. et al. (1998) Fas/Fas ligand signaling during gestational T cell development. J. Immunol., 160, 3766-3775.
4. Kishimoto,H. et al. (1998) A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med., 187, 1427-1438.
5. Krammer,P.H. (2000) CD95's deadly mission in the immune system. Nature, 407, 789-795.
6. Kurasawa,K. et al. (1999) Fas modulates both positive and negative selection of thymocytes. Cell. Immunol., 194, 127-135.
7. Moulian,N. et al. (1998) Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects. Semin. Immunol., 10, 449-456.
8. Schmitz,I. et al. (2003) An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol., 171, 2930-2936.
9. Sprent,J. et al. (2002) The thymus and negative selection. Immunol. Rev., 185, 126-135.
10. Nagata,S. (1996) Fas-induced apoptosis, and diseases caused by its abnormality. Genes Cells, 1, 873-879.
11. Strasser,A. et al. (2009) The many roles of FAS receptor signaling in the immune system. Immunity, 30, 180-192.
12. Villa-Morales,M. et al. (2006) Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma. Oncogene, 25, 2022-2029.
13. Villa-Morales,M. et al. (2007) A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas. Cancer Res., 67, 5107-5116.
14. Nagata,S. et al. (1995) The Fas death factor. Science, 267, 1449-1456.
15. Newton,K. et al. (2000) FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J., 19, 931-941.
16. Zhang,Y. et al. (2005) Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J. Immunol., 175, 3033-3044.
17. Fernandez-Piqueras,J. et al. (2002) Tumor modifier genes. Rev. Oncol., 4, 349-357.
18. Perez-Gomez,E. et al. (2005) Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene, 24, 4450-4461.
19. Legembre,P. et al. (2004) Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. EMBO Rep., 5, 1084-1089.
20. Muschen,M. et al. (2000) Defining CD95 as a tumor suppressor gene. J. Mol. Med., 78, 312-325.
21. Medema,J.P. et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J., 16, 2794-2804.
22. Golstein,P. (2000) Signal transduction. FasL binds preassembled Fas. Science, 288, 2328-2329.
23. Jeong,E.J. et al. (1999) The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J. Biol. Chem., 274, 16337-16342.
24. Papoff,G. et al. (1999) Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem., 274, 38241-38250.
25. Schneider,P. et al. (1997) Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem., 272, 18827-18833.
26. Siegel,R.M. et al. (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol., 1, 469-474.
27. Starling,G.C. et al. (1998) Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Biochemistry, 37, 3723-3726.
28. Kayagaki,N. et al. (1997) Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl Acad. Sci. USA, 94, 3914-3919.
29. Lettau,M. et al. (2008) Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr. Med. Chem., 15, 1684-1696.
30. Carrington,P.E. et al. (2006) The structure of FADD and its mode of interaction with procaspase-8. Mol. Cell, 22, 599-610.
31. Muppidi,J.R. et al. (2006) Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death Differ., 13, 1641-1650.
32. Sandu,C. et al. (2006) FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ., 13, 2052-2061.
33. Valmiki,M.G. et al. (2009) Death effector domain-containing proteins. Cell. Mol. Life Sci., 66, 814-830.
34. Gomez-Angelats,M. et al. (2003) Molecular evidence for the nuclear localization of FADD. Cell Death Differ., 10, 791-797.
35. Hua,Z.C. et al. (2003) A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity, 18, 513-521.
36. Imtiyaz,H.Z. et al. (2009) The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation. J. Biol. Chem., 284, 9917-9926.
37. Park,S.M. et al. (2005) Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell Biol., 17, 610-616.